与此同时,该公司在周二收盘后表示,Idera 不再招募患者进入 tilsotolimod 与 BMS的 Yervoy 和 ...查看全文
$井寺制药(IDRA)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2015-08-06 AccNo: 0001193125-15-279817 Size: 102 KB 网页链接
$井寺制药(IDRA)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2015-08-06 AccNo: 0001193125-15-279815 Size: 140 KB 网页链接
$井寺制药(IDRA)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2015-03-12 AccNo: 0001193125-15-089262 Size: 174 KB 网页链接
$井寺制药(IDRA)$ DEF 14A - Other definitive proxy statements Filed: 2015-04-29 AccNo: 0001193125-15-156728 Size: 995 KB 网页链接
$井寺制药(IDRA)$ ARS [Paper] - Annual Report to Security Holders Film#: 15007039 Filed: 2015-05-11 AccNo: 9999999997-15-010465 Size: 1 KB 网页链接
$井寺制药(IDRA)$ 8-K - Current report Filed: 2015-06-11 AccNo: 0001193125-15-220630 Size: 39 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 5.07: Submission of ...
$井寺制药(IDRA)$ 8-K - Current report Filed: 2015-03-23 AccNo: 0001193125-15-100908 Size: 11 KBItem 8.01: Other Events 网页链接
$井寺制药(IDRA)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2015-08-06 AccNo: 0001193125-15-279797 Size: 3 MB 网页链接
$井寺制药(IDRA)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2015-05-11 AccNo: 0001193125-15-180536 Size: 3 MB 网页链接
$井寺制药(IDRA)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2015-03-12 AccNo: 0001193125-15-088259 Size: 10 MB 网页链接